Castle Biosciences

Yahoo Finance • 7 days ago

Castle Biosciences Named One of Newsweek’s America’s Greatest Companies 2025

FRIENDSWOOD, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has been included in the inaugural 2025 America’s Greatest Compa... Full story

Yahoo Finance • 15 days ago

New Data at American Foregut Society's 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions

FRIENDSWOOD, Texas, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data demonstrating the personalized ris... Full story

Yahoo Finance • last month

Castle Biosciences to Participate in Upcoming Investor Conferences

FRIENDSWOOD, Texas, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to pre... Full story

Yahoo Finance • 2 months ago

Here are the top movers in Tuesday's session.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE COMMENT YMAB [h... Full story

Yahoo Finance • 2 months ago

Tuesday's session: top gainers and losers

Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT YMAB [https://www.chartmill.com/stock/quote/YMAB/profile] 103.... Full story

Yahoo Finance • 2 months ago

Traders are paying attention to the gapping stocks in Tuesday's session.

The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT SMXT [https://www.chartmill.com/stock/qu... Full story

Yahoo Finance • 2 months ago

These stocks are moving in today's pre-market session

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. [premarket] GAINERS TICKER CHANGE COMMENT AIP [https://www.chartmill.com/stock/quote/AIP/... Full story

Yahoo Finance • 2 months ago

Castle Biosciences raises 2025 revenue guidance to $310M–$320M following strong Q2 execution and test volume growth

Earnings Call Insights: Castle Biosciences (CSTL) Q2 2025 MANAGEMENT VIEW * Derek J. Maetzold, CEO, reported that the company “closed out a very successful second quarter that was ahead of our expectations,” citing revenue of $86.2 mil... Full story

Yahoo Finance • 2 months ago

Castle Biosciences Q2 2025 slides: Test volume surges 33% amid declining margins

Introduction & Market Context Castle Biosciences, Inc. (NASDAQ:CSTL) presented its Q2 2025 corporate results on August 4, 2025, highlighting strong test volume growth alongside declining margins and profitability metrics. The molecular di... Full story

Yahoo Finance • 2 months ago

Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference

FRIENDSWOOD, Texas, July 29, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to pre... Full story

Yahoo Finance • 2 months ago

Castle Biosciences’ Founder, President and CEO Derek Maetzold Named a Most Admired CEO by the Houston Business Journal

FRIENDSWOOD, Texas, July 25, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its founder, president and chief executive o... Full story

Yahoo Finance • 2 months ago

Castle Biosciences, Revolution Medicines get FDA breakthrough statuses

[US Food and Drug Administration (FDA)] Castle Biosciences (NASDAQ:CSTL [https://seekingalpha.com/symbol/CSTL]) said on Wednesday that it has received breakthrough device designation from the U.S. Food and Drug Administration for its Deci... Full story

Yahoo Finance • 2 months ago

FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test

FRIENDSWOOD, Texas, July 23, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its DecisionDx-Melanoma test has been grante... Full story

Yahoo Finance • 2 months ago

Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company’s Strong Culture

FRIENDSWOOD, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has earned multiple awards through the 20... Full story

Yahoo Finance • 2 months ago

Castle Biosciences to Release Second Quarter 2025 Financial Results and Host Conference Call on Monday, Aug. 4, 2025

FRIENDSWOOD, Texas, July 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for th... Full story

Yahoo Finance • 3 months ago

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FRIENDSWOOD, Texas, June 19, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June 14, 2025, the Compensation Committee... Full story

Yahoo Finance • 3 months ago

Castle Biosciences partners with SciBase to develop atopic dermatitis test

FRIENDSWOOD, Texas - Castle Biosciences, Inc. (NASDAQ:CSTL), a diagnostic company with a robust gross profit margin of 82% and strong balance sheet showing more cash than debt, has entered into a collaboration and license agreement with Sc... Full story

Yahoo Finance • 3 months ago

Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases

FRIENDSWOOD, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has entered into a collaboration and lice... Full story

Yahoo Finance • 3 months ago

Castle Biosciences’ Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention

FRIENDSWOOD, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, founder, president and chief... Full story

Yahoo Finance • 4 months ago

New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes

FRIENDSWOOD, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will present novel research aimed at enhancing the clinical manage... Full story